Tanarra Credit Partners
4
14M
3
0.25
1
0.25
- Stages of investment
- Areas of investment
Summary
Tanarra Credit Partners appeared to be the Corporate Investor, which was created in 2005. The fund was located in Australia. The main office of represented Corporate Investor is situated in the Melbourne.
The high activity for fund was in 2018. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Genomics, Ultromics. The fund has no exact preference in some founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Life Science, Biotechnology.
The standard case for the fund is to invest in rounds with 8 partakers. Despite the Tanarra Credit Partners, startups are often financed by IP Group Plc, Woodford Investment Management, Oxford Sciences Innovation. The meaningful sponsors for the fund in investment in the same round are Oxford Sciences Innovation, Woodford Investment Management, Vertex Pharmaceuticals. In the next rounds fund is usually obtained by Woodford Investment Management, Vertex Pharmaceuticals, Oxford Sciences Innovation.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 1
- Rounds per year
- 0.25
- Follow on index
- 0.25
- Investments by industry
- Biotechnology (3)
- Health Care (3)
- Medical (3)
- Biopharma (3)
- Life Science (3) Show 10 more
- Investments by region
-
- United Kingdom (4)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 5
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Genomics | 09 Dec 2018 | Biotechnology, Health Care, Genetics, Medical, Life Science, Therapeutics, Biopharma | Early Stage Venture | 9M | England, Oxford, United Kingdom |
Similar funds
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.